bioRxiv preprint doi: https://doi.org/10.1101/474585; this version posted November 21, 2018. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY-NC-ND 4.0 International license. In Silico Determined Properties of Designed Superoxide Dismutase-1 Mutants Predict ALS- like Phenotypes In Vitro and In Vivo Michèle G. DuVal1#, Luke McAlary2,3#, Mona Habibi2, Pranav Garg2, Mine Sher2,3, Neil R. Cashman3, W. Ted Allison1,4,5, and Steven S. Plotkin2,6*. 1. Department of Biological Sciences, University of Alberta, Edmonton, AB, Canada 2. Department of Physics and Astronomy, University of British Columbia, Vancouver, BC, Canada 3. Djavad Mowafaghian Centre for Brain Health, University of British Columbia, Vancouver, BC, Canada 4. Centre for Prions and Protein Folding Disease, University of Alberta, Edmonton, AB, Canada 5. Department of Medical Genetics, University of Alberta, Edmonton, AB, Canada 6. Genome Sciences and Technology Program, University of British Columbia, Vancouver, BC, Canada #These authors contributed equally to the manuscript. *Correspondence to:
[email protected] Abstract The underlying physical causes of SOD1-related ALS are still not well-understood. We address this problem here by computationally designing two de novo mutants, A89R and K128N, which were predicted theoretically to be either significantly destabilizing or stabilizing respectively. We subjected these in silico designed mutants to a series of experimental tests, including in vitro measures of thermodynamic stability, cell-based aggregation and toxicity assays, and an in vivo developmental model of zebrafish motor neuron axonopathy.